Starting from July 2021, AME Publishing Company is formally recognized a publisher member of Committee on Publication Ethics (COPE) and over 60 AME-published journals become a member of Committee on Publication Ethics (COPE), as part of AME’s commitment to best practice in scholarly publishing. Translational Cancer Research (TCR) is among the list of COPE membership.
The Committee on Publication Ethics (COPE) is founded in 1997 by a group of medical journal editors and committed to educating and supporting editors, publishers and those involved in publication ethics. It aims to moving the culture of publishing towards one where ethical practices become a normal part of the publishing culture.
TCR follows the highest standards of publication ethics and apply COPE principles of publication ethics outlined in the Core Practices. By joining COPE, TCR will benefit from accessing all the free and member-only resources from COPE and can also help support COPE's work in promoting publication ethics, and providing advice for editors and publishers.